Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Femke van Wijk

Showing results (91-100 of 110) with videos related to

Pageof 11
Sort By:
Nature Communications|May 12, 2021
Conserved human effector Treg cell transcriptomic and epigenetic signature in arthritic joint inflammationGerdien Mijnheer, Lisanne Lutter, Michal Mokry, et al.
Rheumatology (Oxford, England)|August 13, 2021
Siglec-1 expression on monocytes is associated with the interferon signature in juvenile dermatomyositis and can predict treatment responseButsabong Lerkvaleekul, Saskia R Veldkamp, M Marlot van der Wal, et al.
Gastroenterology|January 21, 2021
Healthy Cotwins Share Gut Microbiome Signatures With Their Inflammatory Bowel Disease Twins and Unrelated PatientsEelco C Brand, Marjolein A Y Klaassen, Ranko Gacesa, et al.
Cell Reports|May 30, 2026
AIRRWAS integrates TCR-microbiome data to reveal how the gut microbiome shapes the circulating and mucosal T cell repertoireRomi Vandoren, My Ha, Vincent M L Van Deuren, et al.
Nature Immunology|January 5, 2023
Human T<sub>H</sub>17 cells engage gasdermin E pores to release IL-1α on NLRP3 inflammasome activationYing-Yin Chao, Alisa Puhach, David Frieser, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|February 28, 2020
Endothelial and Inflammation Biomarker Profiles at Diagnosis Reflecting Clinical Heterogeneity and Serving as a Prognostic Tool for Treatment Response in Two Independent Cohorts of Patients With Juvenile DermatomyositisJudith Wienke, Lauren M Pachman, Gabrielle A Morgan, et al.
Frontiers in Medicine|January 12, 2019
Women in Translational Medicine: Tools to Break the Glass CeilingSophie H Bots, Mira G P Zuidgeest, Aisha Gohar, et al.
Allergy|October 9, 2019
Dupilumab is very effective in a large cohort of difficult-to-treat adult atopic dermatitis patients: First clinical and biomarker results from the BioDay registryLieneke F M Ariëns, Jorien van der Schaft, Daphne S Bakker, et al.
Nature Immunology|January 22, 2013
Transcriptional reprogramming of mature CD4⁺ helper T cells generates distinct MHC class II-restricted cytotoxic T lymphocytesDaniel Mucida, Mohammad Mushtaq Husain, Sawako Muroi, et al.
Immunity|September 25, 2024
Multidimensional profiling of human T cells reveals high CD38 expression, marking recent thymic emigrants and age-related naive T cell remodelingPavla Bohacova, Marina Terekhova, Petr Tsurinov, et al.
Pageof 11

Showing results (91-100 of 110) with videos related to

Sort By:
Pageof 11
Nature Communications|May 12, 2021
Conserved human effector Treg cell transcriptomic and epigenetic signature in arthritic joint inflammationGerdien Mijnheer, Lisanne Lutter, Michal Mokry, et al.
Rheumatology (Oxford, England)|August 13, 2021
Siglec-1 expression on monocytes is associated with the interferon signature in juvenile dermatomyositis and can predict treatment responseButsabong Lerkvaleekul, Saskia R Veldkamp, M Marlot van der Wal, et al.
Gastroenterology|January 21, 2021
Healthy Cotwins Share Gut Microbiome Signatures With Their Inflammatory Bowel Disease Twins and Unrelated PatientsEelco C Brand, Marjolein A Y Klaassen, Ranko Gacesa, et al.
Cell Reports|May 30, 2026
AIRRWAS integrates TCR-microbiome data to reveal how the gut microbiome shapes the circulating and mucosal T cell repertoireRomi Vandoren, My Ha, Vincent M L Van Deuren, et al.
Nature Immunology|January 5, 2023
Human T<sub>H</sub>17 cells engage gasdermin E pores to release IL-1α on NLRP3 inflammasome activationYing-Yin Chao, Alisa Puhach, David Frieser, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|February 28, 2020
Endothelial and Inflammation Biomarker Profiles at Diagnosis Reflecting Clinical Heterogeneity and Serving as a Prognostic Tool for Treatment Response in Two Independent Cohorts of Patients With Juvenile DermatomyositisJudith Wienke, Lauren M Pachman, Gabrielle A Morgan, et al.
Frontiers in Medicine|January 12, 2019
Women in Translational Medicine: Tools to Break the Glass CeilingSophie H Bots, Mira G P Zuidgeest, Aisha Gohar, et al.
Allergy|October 9, 2019
Dupilumab is very effective in a large cohort of difficult-to-treat adult atopic dermatitis patients: First clinical and biomarker results from the BioDay registryLieneke F M Ariëns, Jorien van der Schaft, Daphne S Bakker, et al.
Nature Immunology|January 22, 2013
Transcriptional reprogramming of mature CD4⁺ helper T cells generates distinct MHC class II-restricted cytotoxic T lymphocytesDaniel Mucida, Mohammad Mushtaq Husain, Sawako Muroi, et al.
Immunity|September 25, 2024
Multidimensional profiling of human T cells reveals high CD38 expression, marking recent thymic emigrants and age-related naive T cell remodelingPavla Bohacova, Marina Terekhova, Petr Tsurinov, et al.
Pageof 11